Transporter activity of cysteine mutant with only intact disulfide bridge (Cys-249 and Cys-321 residues) decreases in the presence of DTT, TCEP and GSH. by Rugmani Padmanabhan Iyer (381482)

Decreased capillary density and cardiac fibrosis in <i>Nkx2.5-Cre/Foxm1^fl/fl</i> heart. by Craig Bolte (299486)

Connectivity maps of significantly increased (red) and decreased (blue) cerebellar-cerebral functional connectivity in the adults with major depression, visualized using CARET 5.62 [58], [59]: (A and B) Left hemisphere, (C and D) Right hemisphere. by Li Liu (75607)

Decreased <i>Bgl-</i>FaNaC expression in the left parietal ganglion following <i>S</i>. <i>mansoni</i> infection. by Laura C. Vicente-Rodríguez (16437803)

Decreasing Proportion of Recent Infections among Newly Diagnosed HIV-1 Cases in Switzerland, 2008 to 2013 Based on Line-Immunoassay-Based Algorithms by Jörg Schüpbach (82530)

Decreased α-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository by Fidéline Bonnet-Serrano (4782546)

Synopsis of the drugs administered in a multimodal anaesthetic protocol regimen along with propofol. by Chiara E. Hampton (16484687)

Subjects:

DHA does not affect the expression of IFNγR1 & R2 but decreases STAT1 phosphorylation in non-infected J774A.1 cells primed with IFNγ. by Diana L. Bonilla (248104)

Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

PDGF-BB-induced NR4A1 expression is decreased after treatment with the NF-κB inhibitor BAY11-7082. by Glenda Eger (636934)

Image_1_Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis.jpeg by Yunwei Hu (9021272)

“…The number of patients in each study ranged from 11 to 163 and the mean follow-up time from 0.9 to 6.44 years. During the follow-up, the pooled inflammation remission rate was 68% with a 95% confidence interval (CI) of 0.59–0.79, VA improvement rate was 60% (95% CI 0.47–0.77), CMT decrease was 112.70 μm (95% CI 72.8–153.0 μm). …”

Table_1_Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis.docx by Yunwei Hu (9021272)

“…The number of patients in each study ranged from 11 to 163 and the mean follow-up time from 0.9 to 6.44 years. During the follow-up, the pooled inflammation remission rate was 68% with a 95% confidence interval (CI) of 0.59–0.79, VA improvement rate was 60% (95% CI 0.47–0.77), CMT decrease was 112.70 μm (95% CI 72.8–153.0 μm). …”

Survival is prolonged when the G59S mutant dynactin is placed on the B6 background and decreased when it is placed on the B6 background compared to the original mixed background (B... by Terry D. Heiman-Patterson (580597)

Mean contacts over time by age and by age and setting with timeline of survey participation with 95% CI of bootstrapped mean. by Amy Gimma (8809463)

Stacked bar plots of predicted absolute IPD cases per year from 2006 to 2031 in Germany for three different age groups (<2y, 16-59y, ≥60y). by Matthias Horn (78815)

Overall and regional trends of anemia among children age 6–59 months by survey year. by Samnang Um (14990562)

The fraction of predicted heterozygotes that are set to “No Call” by RHA decreases as the size of the heterozygote cluster increases. by Orna Mizrahi-Man (42539)

Decrease in DNA methylation level in NOR-1 and NOR-2 of <i>Q.robur</i> following treatment with 5-aza-2′-dC. by Vedrana Vičić Bočkor (610205)

Pim overexpression increases and Pim inhibition by DHPCC-9 decreases growth of orthotopic prostate xenografts. by Niina M. Santio (279874)

Image1_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF by Gabriella Gálffy (177759)

“…The COVID-19 pandemic resulted in a statistically significant decrease in lung cancer incidence, especially in the 50–59 age group (both sexes).…”